In8bio
INAB

In8bio (INAB) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$6.00Mar 13, 2026
HC Wainwright & Co.MaintainedBuy$6.00 from $8.00Mar 14, 2025
HC Wainwright & Co.MaintainedBuy$8.00Feb 12, 2025
Jones TradingUpgradedHold → Buy$1.20Feb 11, 2025
HC Wainwright & Co.MaintainedBuy$8.00Nov 26, 2024
HC Wainwright & Co.MaintainedBuy$8.00 from $12.50Nov 13, 2024
Jones TradingDowngradedBuy → HoldAug 12, 2024
HC Wainwright & Co.MaintainedBuy$12.50Jun 14, 2024
Jones TradingMaintainedBuy$6.50 from $5.00Jun 14, 2024
HC Wainwright & Co.MaintainedBuy$12.50Jun 4, 2024
HC Wainwright & Co.MaintainedBuy$12.50 from $14.00May 13, 2024
HC Wainwright & Co.MaintainedBuy$14.00Apr 10, 2024
Laidlaw & Co.Initiated CoverageBuy$7.50Mar 18, 2024
HC Wainwright & Co.MaintainedBuy$14.00Mar 15, 2024
JonesTradingInitiated CoverageBuy$5.00Mar 13, 2024
HC Wainwright & Co.MaintainedBuy$14.00Nov 13, 2023
HC Wainwright & Co.MaintainedBuy$14.00Aug 11, 2023
EF HuttonMaintainedBuy$8.00Jun 5, 2023
HC Wainwright & Co.MaintainedBuy$14.00May 16, 2023

Frequently asked questions

  • What is the latest analyst rating on INAB?

    On Mar 13, 2026, HC Wainwright & Co. maintained In8bio at Buy with a price target of $6.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.